The Davol/C.R. Bard hernia mesh complication class action represents one of the largest settlements in medical device litigation, with a roughly $1 billion agreement reached to resolve approximately 38,000 hernia mesh lawsuits filed across federal and state courts. This global settlement was created to compensate patients who suffered serious complications from Bard’s hernia mesh products, including infection, chronic pain, organ damage, and nerve damage that in some cases proved life-threatening or fatal. The litigation has been ongoing for years, with recent verdicts demonstrating the severity of injuries—including a $4.8 million award to a Rhode Island man who suffered gastrointestinal injuries from Ventralex™ hernia mesh complications. The class action, formally titled “In re: Davol, Inc./C.R.
Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation MDL No. 2846,” consolidated thousands of individual cases into a coordinated proceeding. As of January 2026, approximately 23,749 hernia mesh complication claims remain pending against C.R. Bard, even with the large settlement in place. If you underwent hernia repair surgery using Bard mesh products and subsequently experienced complications, you may be eligible to file a claim for compensation.
Table of Contents
- What Is the Davol/Bard Hernia Mesh MDL Litigation?
- What Medical Complications Has Bard Hernia Mesh Caused?
- What Is the Settlement Amount and What Is Its Current Status?
- How Much Compensation Can I Expect from the Davol/Bard Settlement?
- What Are the Delays and Issues with the Settlement Claims Portal?
- Who Is Eligible to File a Claim in the Davol/Bard Settlement?
- What Happens Next with the Remaining 23,749 Pending Claims?
What Is the Davol/Bard Hernia Mesh MDL Litigation?
The Davol/Bard hernia mesh class action is a multidistrict litigation (MDL) consolidated under MDL No. 2846 in federal court. MDLs are used when multiple lawsuits involving similar claims against the same defendant are filed across different jurisdictions. Instead of having hundreds or thousands of separate trials, the cases are consolidated for coordinated pretrial proceedings. This approach allows for more efficient management of complex product liability cases while ensuring fairness to all plaintiffs. C.R.
Bard manufactures hernia mesh products under brand names including Ventralex™ and other polypropylene mesh devices. Hernia mesh repair is a common surgical procedure—millions of Americans undergo hernia surgery each year. The mesh is implanted to reinforce the weak area of tissue where the hernia occurred. However, numerous patients reported that the mesh caused severe complications rather than healing properly. The litigation encompasses products manufactured and sold over many years, with some cases involving mesh implanted in the 1990s and 2000s. The scale of this MDL is significant. The nearly 38,000 cases included in the settlement demonstrate that complications from Bard’s hernia mesh products were not isolated incidents but a widespread problem affecting tens of thousands of patients nationwide.
What Medical Complications Has Bard Hernia Mesh Caused?
Patients who developed complications from Bard hernia mesh products reported a range of serious injuries, from chronic pain to organ damage and life-threatening infections. Common complications include persistent pain at the surgical site, infections that occur months or even years after implantation, adhesions (where internal organs stick together), and nerve damage causing numbness or burning sensations. In more severe cases, patients suffered bowel perforation, intestinal obstruction, and other gastrointestinal injuries requiring additional surgeries. One documented case involved a patient who received Ventralex™ hernia mesh and subsequently suffered severe gastrointestinal injuries—this plaintiff recovered a $4.8 million verdict, reflecting the serious nature of mesh-related complications.
The fact that such substantial verdicts have been awarded demonstrates that courts recognize the genuine harm caused by defective hernia mesh products. However, not all claims result in large verdicts; individual outcomes vary based on the specific injuries, medical evidence, and circumstances of each case. A critical limitation to understand is that not all post-surgical pain or complications are necessarily caused by the mesh itself. Proving causation—that the Bard mesh specifically caused the injury rather than other factors—requires medical evidence and expert testimony. This is why working with an experienced attorney is important for evaluating whether your complications may have been caused by the mesh product.
What Is the Settlement Amount and What Is Its Current Status?
The global settlement agreement totals approximately $1 billion and was created to resolve the pending lawsuits more efficiently than pursuing thousands of individual trials. The settlement fund was established in January 2025, with defendant payments scheduled to begin before the end of 2025. This represents a significant financial commitment by Bard and reflects the strength of the plaintiffs’ claims. The settlement covers approximately 38,000 hernia mesh complication cases that were consolidated in the MDL. The agreement establishes a claims process through which eligible patients can apply for compensation without having to go to trial.
This provides a faster, more predictable path to compensation compared to waiting years for individual trials to conclude. However, the settlement process has not been without obstacles—the Crosslink settlement portal experienced technical issues that delayed the claims process, pushing the original March 17, 2025 deadline back several months. As of April 2026, the settlement is still being administered, with claims continuing to be processed. Some claimants have already received payments, while others are still waiting for their claims to be reviewed and approved. The technical delays in the portal have caused frustration for claimants expecting faster resolution, highlighting that even with a negotiated settlement, the actual compensation process can take considerable time.
How Much Compensation Can I Expect from the Davol/Bard Settlement?
The average compensation range for hernia mesh complications is expected to be between $60,000 and $100,000 per claimant. This range reflects the settlement’s goal of fairly compensating patients for medical expenses, pain and suffering, lost wages, and other damages related to their mesh complications. However, this is an average—actual compensation amounts will vary significantly based on individual circumstances. Several factors influence how much a claimant may receive: the severity of the injury, the medical expenses incurred, whether additional surgeries were required, the degree of permanent disability, and the strength of the evidence connecting the injury to the Bard mesh.
A patient who experienced chronic pain alone may receive less compensation than one who suffered organ damage requiring multiple surgeries. The $500,000 verdict awarded to Aaron Stinson in November 2023, and the $4.8 million verdict for gastrointestinal injuries, demonstrate that in cases that proceed to trial (rather than settling), compensation can substantially exceed the average settlement range. However, a critical tradeoff is that going to trial is riskier and takes longer than accepting a settlement—you could win more, but you could also win less or lose entirely. The settlement framework provides a degree of predictability compared to litigation risk, but individual settlement amounts remain subject to claims review processes that evaluate the specific evidence in each case.
What Are the Delays and Issues with the Settlement Claims Portal?
One of the major challenges with the Davol/Bard settlement has been technical problems with the Crosslink settlement portal, the online system through which claimants submit their claims and documentation. The portal experienced significant difficulties that pushed back the original claims deadline of March 17, 2025 by several months. This delay frustrated many claimants who were expecting to submit their claims and receive compensation on a specific timeline. Portal issues have included website outages, difficulty uploading documentation, problems creating accounts, and slow processing of submitted claims.
These technical glitches have meant that claimants had to wait longer than anticipated for their claims to be processed, and in some cases had to resubmit documentation multiple times. When dealing with a settlement portal, it is important to keep detailed records of everything you submit, including confirmation numbers and dates of submission, in case technical issues require you to resubmit documentation. A key warning: do not rely on the settlement portal’s estimated timeline projections for payment. While the settlement was structured with specific payment phases, portal delays and administrative processing have consistently pushed those timelines back. Contact the claims administrator directly if you have questions about your specific claim status rather than assuming you know when payment will arrive.
Who Is Eligible to File a Claim in the Davol/Bard Settlement?
To be eligible for the settlement, you must have received a hernia repair surgery using a Davol or C.R. Bard polypropylene hernia mesh product (including products like Ventralex™) and subsequently suffered complications that you believe were caused by the mesh. Eligible complications include infection, pain, adhesions, organ damage, nerve damage, bowel perforation, and other mesh-related injuries that required additional medical treatment.
You will need documentation showing that you received the mesh implant, along with medical records documenting the complications you experienced after implantation. If your hernia repair occurred many years ago, you may need to obtain older medical records from your surgeon’s office or hospital. The settlement is open to patients regardless of which state they live in or where the surgery was performed, though the claim process does require submitting evidence to support your claim.
What Happens Next with the Remaining 23,749 Pending Claims?
As of January 2026, approximately 23,749 hernia mesh complication claims remain pending against C.R. Bard despite the $1 billion settlement. This includes both claims that have been filed in the MDL but not yet settled, and claims from patients who have not yet joined the settlement. The settlement process is expected to continue over the next several years as remaining claims are processed and paid out.
The presence of nearly 24,000 pending claims indicates that the litigation is far from over. Some claimants may choose to pursue their cases outside the settlement, particularly if they believe they have evidence of exceptionally severe injuries that could result in verdicts exceeding the settlement’s average compensation range. Others may opt into the settlement as it becomes finalized, seeking the certainty of a settlement payment over the uncertainty of litigation. The timeline for final resolution of all pending claims remains uncertain, though recent settlement activity suggests that most cases should be resolved within the next few years.
You Might Also Like
- Hernia Mesh Adhesion Infection Complication Class Action
- Covidien Hernia Mesh Complication Class Action
- Atrium C-Qur Hernia Mesh Complication Class Action
Open Settlements You Can Claim Now
Browse current class action settlements accepting claims — several require no proof of purchase: